Different treatment strategies for BRCA positive breast cancer
Different treatment strategies for BRCA positive breast cancer
Neoadjuvant and adjuvant therapy in triple negative breast cancer
The DESKTOPIII trial in platinum-sensitive ovarian cancer
Expert insight: Managing neutropenia in breast cancer patients
Focus on screening, not biomarkers
Venetoclax plus rituximab for patients with relapsed / refractory CLL
Daratumumab plus bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone for multiple myeloma
Multiple myeloma analysis from ASH 2017
Multiple myeloma highlights from ASH 2017
ASH 2017: Immunotherapy for multiple myeloma
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in multiple myeloma
REGN2810 alone or in combination with REGN1979 for B-lymphoid malignancies